|
000
| 01845nam 2200373zi 4500 |
|---|
| 001 | 9.875874 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107164548 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 190704t20192019onc |ob f00| 0 eng d |
|---|
| 020 | |a9780660317496 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-284/2019E-PDF |
|---|
| 245 | 00|aManagement of applications and performance for drug establishment licences (GUI-0127). |
|---|
| 246 | 17|aGUI-0127 : |bmanagement of applications and performance for drug establishment licences |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2019. |
|---|
| 264 | 4|c©2019 |
|---|
| 300 | |a1 online resource (34 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Gestion des demandes et du rendement en matière de licences d’établissement de produits pharmaceutiques (GUI-0127). |
|---|
| 500 | |a"Date issued: November 27, 2019." |
|---|
| 500 | |a"Date implemented: April 1, 2020." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (pages 29-31). |
|---|
| 650 | 0|aPharmaceutical industry|xLicenses|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tGestion des demandes et du rendement en matière de licences d’établissement de produits pharmaceutiques.|w(CaOODSP)9.875873 |
|---|
| 856 | 40|qPDF|s589 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H164-284-2019-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/management-applications-performance-drug-establishment-licences-0127/document.html |
|---|